2026 Q1 -tulosraportti
Vain PDF
48 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·23 t sitten · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
·1 päivä sitten · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!- ·19.6.Good news is always welcome, thank you. Now there can hardly be any doubt that Weeco astrum10-10 will be a cash caw for Stenocare. Since Weeco atrum10-10 is considered and approved as general medicine, it will also not be affected if the subsidy for all medical cannabis is reduced. The subsidy for flower medicine and vaporizers stops as of January 1, 2027. In this regard, Hanf magasinet has written an article stating that the best alternative is oils and extracts. The German Ministry of Health has published Location: Page 2, section 2. The government's argument for excluding flowers: The text states that the German Ministry of Health (BMG) will limit health insurance coverage so that it will only apply to "extracts of standardized quality, finished medicinal products, and medicinal products with the active substances Dronabinol and Nabilon". Dried flowers are to be completely excluded. Why oil/extract is the safe alternative: Immediately after, the text describes the ministry's official justification to the market. The ministry argues that smoking/inhalation of flowers poses an unnecessary "erhøjet suchtgefahr" (increased risk of addiction) due to the excessively rapid absorption into the blood. Furthermore, they criticize that flowers as a natural product have too large fluctuations in active substance content. Conclusion in the legal text: The ministry states that "within the framework of a medical therapy, standardized extracts and finished medicinal products are principally indicated [red: the right choice] over getrockneten Blüten, as a higher standardization of active substance content can be achieved with these." I found the above with the help of Google, and it has been translated with the help of Google. Hanf magasin. https://www.hanf-magazin.com/en/gkv-soll-cannabis-blueten-nicht-mehr-erstatten/ German Ministry of Health https://cannabiswirtschaft.de/wp-content/uploads/2026/04/BvCW-Stellungnahme-BStabG-2026-04-19.pdfI have muted Overleif, because I hold the view that there is freedom of speech, and the same applies to what I have to listen to. Since he has nothing constructive to offer, neither positive nor negative, but only has a single purpose, which is to spread bad mood, in all the places where he has lost money, and it seems that many investments have gone wrong, according to himself. Instead of learning from it, he apparently believes that we should listen to it every time he has thrown good money after bad investments. Therefore, I have chosen to put Overleif on mute.
- ·18.6.Stock status Canngo; all 3 pharmacies have the oil in stock. It is a total of 8 times, in the last 3 weeks, that these pharmacies have been sold out. The rest status quo
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
48 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sitten · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
- ·1 päivä sitten · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!
- ·19.6.Good news is always welcome, thank you. Now there can hardly be any doubt that Weeco astrum10-10 will be a cash caw for Stenocare. Since Weeco atrum10-10 is considered and approved as general medicine, it will also not be affected if the subsidy for all medical cannabis is reduced. The subsidy for flower medicine and vaporizers stops as of January 1, 2027. In this regard, Hanf magasinet has written an article stating that the best alternative is oils and extracts. The German Ministry of Health has published Location: Page 2, section 2. The government's argument for excluding flowers: The text states that the German Ministry of Health (BMG) will limit health insurance coverage so that it will only apply to "extracts of standardized quality, finished medicinal products, and medicinal products with the active substances Dronabinol and Nabilon". Dried flowers are to be completely excluded. Why oil/extract is the safe alternative: Immediately after, the text describes the ministry's official justification to the market. The ministry argues that smoking/inhalation of flowers poses an unnecessary "erhøjet suchtgefahr" (increased risk of addiction) due to the excessively rapid absorption into the blood. Furthermore, they criticize that flowers as a natural product have too large fluctuations in active substance content. Conclusion in the legal text: The ministry states that "within the framework of a medical therapy, standardized extracts and finished medicinal products are principally indicated [red: the right choice] over getrockneten Blüten, as a higher standardization of active substance content can be achieved with these." I found the above with the help of Google, and it has been translated with the help of Google. Hanf magasin. https://www.hanf-magazin.com/en/gkv-soll-cannabis-blueten-nicht-mehr-erstatten/ German Ministry of Health https://cannabiswirtschaft.de/wp-content/uploads/2026/04/BvCW-Stellungnahme-BStabG-2026-04-19.pdfI have muted Overleif, because I hold the view that there is freedom of speech, and the same applies to what I have to listen to. Since he has nothing constructive to offer, neither positive nor negative, but only has a single purpose, which is to spread bad mood, in all the places where he has lost money, and it seems that many investments have gone wrong, according to himself. Instead of learning from it, he apparently believes that we should listen to it every time he has thrown good money after bad investments. Therefore, I have chosen to put Overleif on mute.
- ·18.6.Stock status Canngo; all 3 pharmacies have the oil in stock. It is a total of 8 times, in the last 3 weeks, that these pharmacies have been sold out. The rest status quo
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
48 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sitten · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
- ·1 päivä sitten · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!
- ·19.6.Good news is always welcome, thank you. Now there can hardly be any doubt that Weeco astrum10-10 will be a cash caw for Stenocare. Since Weeco atrum10-10 is considered and approved as general medicine, it will also not be affected if the subsidy for all medical cannabis is reduced. The subsidy for flower medicine and vaporizers stops as of January 1, 2027. In this regard, Hanf magasinet has written an article stating that the best alternative is oils and extracts. The German Ministry of Health has published Location: Page 2, section 2. The government's argument for excluding flowers: The text states that the German Ministry of Health (BMG) will limit health insurance coverage so that it will only apply to "extracts of standardized quality, finished medicinal products, and medicinal products with the active substances Dronabinol and Nabilon". Dried flowers are to be completely excluded. Why oil/extract is the safe alternative: Immediately after, the text describes the ministry's official justification to the market. The ministry argues that smoking/inhalation of flowers poses an unnecessary "erhøjet suchtgefahr" (increased risk of addiction) due to the excessively rapid absorption into the blood. Furthermore, they criticize that flowers as a natural product have too large fluctuations in active substance content. Conclusion in the legal text: The ministry states that "within the framework of a medical therapy, standardized extracts and finished medicinal products are principally indicated [red: the right choice] over getrockneten Blüten, as a higher standardization of active substance content can be achieved with these." I found the above with the help of Google, and it has been translated with the help of Google. Hanf magasin. https://www.hanf-magazin.com/en/gkv-soll-cannabis-blueten-nicht-mehr-erstatten/ German Ministry of Health https://cannabiswirtschaft.de/wp-content/uploads/2026/04/BvCW-Stellungnahme-BStabG-2026-04-19.pdfI have muted Overleif, because I hold the view that there is freedom of speech, and the same applies to what I have to listen to. Since he has nothing constructive to offer, neither positive nor negative, but only has a single purpose, which is to spread bad mood, in all the places where he has lost money, and it seems that many investments have gone wrong, according to himself. Instead of learning from it, he apparently believes that we should listen to it every time he has thrown good money after bad investments. Therefore, I have chosen to put Overleif on mute.
- ·18.6.Stock status Canngo; all 3 pharmacies have the oil in stock. It is a total of 8 times, in the last 3 weeks, that these pharmacies have been sold out. The rest status quo
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt